GLP-1 medications like Mounjaro and Wegovy have become popular for managing weight and blood sugar levels. While effective, these drugs often come with side effects such as nausea, diarrhea, acid reflux, and sulphur burps. What many people don’t realize is that certain foods and drinks can make these side effects worse. In particular, diets high in saturated fats and sugary beverages like fizzy drinks and alcohol can increase discomfort. Understanding how these dietary choice

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

Mounjaro doesn’t “speed up” metabolism in the traditional sense, but it improves how your body processes glucose and stores energy. By enhancing insulin sensitivity and reducing appetite, it helps the body use energy more efficiently. Over time, this balance can lead to gradual fat loss and better overall metabolic health. How Mounjaro supports metabolic function Metabolism is the body’s process of converting food into energy. NICE (TA1026, 2025) explains that tirzepatide — t

Mounjaro was developed by the pharmaceutical company Eli Lilly and first approved for medical use in 2022. It’s based on years of research into dual hormone therapies that target both GIP and GLP-1 pathways. Its effectiveness has since been demonstrated in large international trials, helping establish it as a new generation of treatment for type 2 diabetes and weight management. How Mounjaro began The story of Mounjaro started in the early 2010s, when researchers explored way

Mounjaro was developed by the pharmaceutical company Eli Lilly and first approved for medical use in 2022. It’s based on years of research into dual hormone therapies that target both GIP and GLP-1 pathways. Its effectiveness has since been demonstrated in large international trials, helping establish it as a new generation of treatment for type 2 diabetes and weight management. How Mounjaro began The story of Mounjaro started in the early 2010s, when researchers explored way

Mounjaro doesn’t “speed up” metabolism in the traditional sense, but it improves how your body processes glucose and stores energy. By enhancing insulin sensitivity and reducing appetite, it helps the body use energy more efficiently. Over time, this balance can lead to gradual fat loss and better overall metabolic health. How Mounjaro supports metabolic function Metabolism is the body’s process of converting food into energy. NICE (TA1026, 2025) explains that tirzepatide — t

Support starts with your prescribing service: nurse-led education, injection training, and scheduled reviews. Pharmacists can help with device checks, storage questions, and travel letters. Many NHS weight-management programmes offer dietitian input and behaviour support; local availability differs by nation and Integrated Care Board / health board. Stick to official resources for technique and safety; if something online conflicts with your pen’s leaflet or clinic advice, fo

Wegovy is compatible with vegetarian or vegan eating, but plan protein (beans, lentils, tofu/tempeh, mycoprotein), iron, iodine, calcium and B12 carefully — lower appetite can make hitting targets harder. A simple “protein first” rule at meals and a daily multivitamin that fits your diet can help, alongside routine blood work if your clinician advises. For coeliac disease or other medical diets, your team will integrate Wegovy around the existing plan rather than replace it.

Support starts with your prescribing service: nurse-led education, injection training, and scheduled reviews. Pharmacists can help with device checks, storage questions, and travel letters. Many NHS weight-management programmes offer dietitian input and behaviour support; local availability differs by nation and Integrated Care Board / health board. Stick to official resources for technique and safety; if something online conflicts with your pen’s leaflet or clinic advice, fo

Wegovy is compatible with vegetarian or vegan eating, but plan protein (beans, lentils, tofu/tempeh, mycoprotein), iron, iodine, calcium and B12 carefully — lower appetite can make hitting targets harder. A simple “protein first” rule at meals and a daily multivitamin that fits your diet can help, alongside routine blood work if your clinician advises. For coeliac disease or other medical diets, your team will integrate Wegovy around the existing plan rather than replace it.

Yes — psychological context matters. Calmer appetite can ease emotional or stress-linked eating, but it doesn’t replace mental-health care. Set expectations early, watch for mood changes, and use behavioural tools (meal planning, mindful eating, sleep routines). If you’ve had disordered-eating patterns, tell your clinician so support can be tailored; brief check-ins with a dietitian or counsellor often make the process smoother. Why psychology is part of treatment Weight mana

Yes — psychological context matters. Calmer appetite can ease emotional or stress-linked eating, but it doesn’t replace mental-health care. Set expectations early, watch for mood changes, and use behavioural tools (meal planning, mindful eating, sleep routines). If you’ve had disordered-eating patterns, tell your clinician so support can be tailored; brief check-ins with a dietitian or counsellor often make the process smoother. Why psychology is part of treatment Weight mana

Yes — seasonal extremes matter. In summer, protect pens from heat; don’t leave them in cars or direct sun, and use an insulated pouch for journeys. In winter, guard against freezing (a frozen pen must not be used). Unopened pens stay refrigerated; in-use pens can usually be kept below 30 °C for the leaflet-specified period, cap on and away from light. If you suspect overheating or freezing, ask your pharmacist before using the pen. Why temperature control matters Wegovy (sema

Yes — seasonal extremes matter. In summer, protect pens from heat; don’t leave them in cars or direct sun, and use an insulated pouch for journeys. In winter, guard against freezing (a frozen pen must not be used). Unopened pens stay refrigerated; in-use pens can usually be kept below 30 °C for the leaflet-specified period, cap on and away from light. If you suspect overheating or freezing, ask your pharmacist before using the pen. Why temperature control matters Wegovy (sema

Yes — many services use Wegovy for maintenance when it remains clinically appropriate and well tolerated, but continuation depends on local commissioning rules. Some pathways set time limits or review benchmarks; others allow ongoing use if benefits and safety are clear. Whatever the policy, maintenance also relies on stable habits (protein, fibre, steps, simple strength work) so that stopping — if and when it happens — doesn’t trigger rapid regain. Scotland and Wales may fra

Yes — many services use Wegovy for maintenance when it remains clinically appropriate and well tolerated, but continuation depends on local commissioning rules. Some pathways set time limits or review benchmarks; others allow ongoing use if benefits and safety are clear. Whatever the policy, maintenance also relies on stable habits (protein, fibre, steps, simple strength work) so that stopping — if and when it happens — doesn’t trigger rapid regain. Scotland and Wales may fra

Short training is strongly recommended and widely offered by nurses or pharmacists. A hands-on demo covers device setup, priming (if applicable), 90° angle, site rotation, and how long to hold the pen in place — five minutes of practice prevents most errors. You’ll also get storage, travel, and missed-dose guidance, and a chance to ask questions. Refresher sessions are useful if you switch strengths or pens. Why training matters Wegovy (semaglutide) is designed for self-injec

Short training is strongly recommended and widely offered by nurses or pharmacists. A hands-on demo covers device setup, priming (if applicable), 90° angle, site rotation, and how long to hold the pen in place — five minutes of practice prevents most errors. You’ll also get storage, travel, and missed-dose guidance, and a chance to ask questions. Refresher sessions are useful if you switch strengths or pens. Why training matters Wegovy (semaglutide) is designed for self-injec